854 related articles for article (PubMed ID: 18973795)
1. Aquaporin 4 deficiency modulates morphine pharmacological actions.
Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
[TBL] [Abstract][Full Text] [Related]
2. Effects of aquaporin4 deficiency on opioid receptors characteristics in naive and chronic morphine-treated mice.
Wang JF; Wang ZY; Wu N; Yan HT; Li J
Neurosci Lett; 2009 Jul; 457(3):111-4. PubMed ID: 19429174
[TBL] [Abstract][Full Text] [Related]
3. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
4. Effects of aquaporin 4 deficiency on morphine analgesia and chronic tolerance: a study at spinal level.
Chen ML; Bao F; Zhang YQ; Zhao ZQ
J Mol Neurosci; 2010 Oct; 42(2):140-4. PubMed ID: 20387009
[TBL] [Abstract][Full Text] [Related]
5. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
9. Effects of aquaporin 4 deficiency on the expression of spinal PKCα, PKCγ and c-Fos in naloxone-precipitated morphine withdrawal mice.
Chen ML; Bao F; Zhang YQ; Zhao ZQ
Sheng Li Xue Bao; 2012 Aug; 64(4):365-71. PubMed ID: 22907296
[TBL] [Abstract][Full Text] [Related]
10. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes.
Zeng XN; Sun XL; Gao L; Fan Y; Ding JH; Hu G
Mol Cell Neurosci; 2007 Jan; 34(1):34-9. PubMed ID: 17074507
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role of CaMKIV in the development of opioid analgesic tolerance.
Ko SW; Jia Y; Xu H; Yim SJ; Jang DH; Lee YS; Zhao MG; Toyoda H; Wu LJ; Chatila T; Kaang BK; Zhuo M
Eur J Neurosci; 2006 Apr; 23(8):2158-68. PubMed ID: 16630062
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
14. Aquaporin-4 deficiency attenuates opioid dependence through suppressing glutamate transporter-1 down-regulation and maintaining glutamate homeostasis.
Yan HT; Wu N; Lu XQ; Su RB; Zheng JQ; Li J
CNS Neurosci Ther; 2013 Jan; 19(1):12-9. PubMed ID: 23051665
[TBL] [Abstract][Full Text] [Related]
15. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.
Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
Yano I; Takemori AE
Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
[TBL] [Abstract][Full Text] [Related]
18. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
Roychoudhury M; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
[TBL] [Abstract][Full Text] [Related]
19. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
[TBL] [Abstract][Full Text] [Related]
20. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
